Aspira Womens Health Inc (AWH) - Financial and Strategic SWOT Analysis Review

Summary

Aspira Womens Health Inc (Aspira), formerly Vermillion Inc, is a medical device company that discovers, develops and markets diagnostic and bio-analytical solutions that supports physicians to diagnose, treat and improve gynecologic health outcomes for women. The companys in vitro diagnostic test OVA1, a simple blood test, which measures the levels of proteins found in the blood and then uses proprietary software to calculate a single score. Its other products includes OVERA, a second-generation biomarker panel intended to maintain OVA1s high sensitivity while improving specificity; OVA1plus; Aspira GenetiX, a genetic test for gynecologic cancer risk, with a core focus on female reproductive cancers, including breast, ovarian, endometrial, uterine and cervical cancers, and Aspira Synergy, our new decentralized platform and cloud service technology. Its research and development center develops and validates biomarkers and algorithms. The company serves CROs, pharma, biotech and medical device industries across the US. Aspira is headquartered in Austin, Texas, the US.

Aspira Womens Health Inc Key Recent Developments

Sep 30,2021: Aspira Womens Health, Black Womens Health Imperative Lead Congressional Briefing
Jul 27,2021: Aspira Womens Health to Report Second Quarter 2021 Financial Results on August 12
May 19,2021: Aspira Womens Health to Participate in the William Blair Growth Stock Conference
May 13,2021: Aspira Womens Health Reports First Quarter 2021 Financial Results
May 05,2021: Aspira Womens Health to Report First Quarter 2021 Financial Results on May 13

This comprehensive SWOT profile of Aspira Womens Health Inc provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Aspira Womens Health Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents

Section 1 - About the Company

Aspira Womens Health Inc - Key Information
Aspira Womens Health Inc - Overview
Aspira Womens Health Inc - Key Employees
Aspira Womens Health Inc - Key Employee Biographies
Aspira Womens Health Inc - Key Operational Heads
Aspira Womens Health Inc - Major Products and Services
Aspira Womens Health Inc - History
Aspira Womens Health Inc - Company Statement
Aspira Womens Health Inc - Locations And Subsidiaries
Aspira Womens Health Inc
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Aspira Womens Health Inc - Business Description
Aspira Womens Health Inc - Corporate Strategy
Aspira Womens Health Inc - SWOT Analysis
SWOT Analysis - Overview
Aspira Womens Health Inc - Strengths
Aspira Womens Health Inc - Weaknesses
Aspira Womens Health Inc - Opportunities
Aspira Womens Health Inc - Threats
Aspira Womens Health Inc - Key Competitors

Section 3 - Company Financial Performance Charts

Aspira Womens Health Inc - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company

List Of Tables

List of Tables

Aspira Womens Health Inc, Key Information
Aspira Womens Health Inc, Key Ratios
Aspira Womens Health Inc, Share Data
Aspira Womens Health Inc, Major Products and Services
Aspira Womens Health Inc, History
Aspira Womens Health Inc, Key Employees
Aspira Womens Health Inc, Key Employee Biographies
Aspira Womens Health Inc, Key Operational Heads
Aspira Womens Health Inc, Other Locations
Aspira Womens Health Inc, Subsidiaries
Aspira Womens Health Inc, Key Competitors
Aspira Womens Health Inc, SWOT Analysis
Aspira Womens Health Inc, Ratios based on current share price
Aspira Womens Health Inc, Annual Ratios
Aspira Womens Health Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

List of Figures

Aspira Womens Health Inc, Performance Chart
Aspira Womens Health Inc, Ratio Charts

Meconium Aspiration Syndrome (MAS) Global Clinical Trials Review, H2, 2017

Meconium Aspiration Syndrome (MAS) Global Clinical Trials Review, H2, 2017GlobalDatas clinical trial report, Meconium Aspiration Syndrome (MAS) Global Clinical Trials Review, H2, 2017 provides an overview of Meconium Aspiration Syndrome

USD 2500 View Report

Global Womens Health Therapeutics Market 2022 - Industry Briefing

The global womens health therapeutics market is likely to register a CAGR of over 5.4% with an incremental growth of USD 21 billion during the forecast period 2022-2028.This industry report

USD 950 View Report

Premature Ovarian Failure (Womens Health) - Drugs in Development, 2021

Premature Ovarian Failure (Womens Health) - Drugs in Development, 2021Premature Ovarian Failure (Womens Health) - Drugs in Development, 2021 provides an overview of the Premature Ovarian Failure pipeline landscape.The report

USD 2000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available